News Daily News TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State Michael O'Riordan January 22, 2020
News Daily News FDA Approves Baroreflex Activation Therapy Device for Advanced Heart Failure Todd Neale August 19, 2019
News Daily News Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers L.A. McKeown April 19, 2019
News Conference News ACC 2019 PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital Michael O'Riordan March 25, 2019
News Daily News FDA Approves HeartMate 3 as Destination Therapy in Advanced HF Michael O'Riordan October 19, 2018
News Daily News HeartMate 3 Problem With Outflow Graft Twisting Called Class I Recall by FDA Todd Neale May 23, 2018
News Daily News FDA Grants HeartWare LVAD a Destination Therapy Indication Todd Neale September 28, 2017
News Features A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease Yael L. Maxwell August 02, 2017
News Daily News HeartMate II Left Ventricular Assist System Under Recall Due to Controller Exchange Problems Todd Neale May 24, 2017
News Opinion Fellow Talk Hemodynamics Galore: What I Learned at the C3 Summit Tiffany Patterson, MBBS July 27, 2016
News Daily News Good Guys, Bad Guys, or Just Big Money? The Push to Link Patient-Claims Data to Device Outcomes Shelley Wood March 17, 2016
News Industry News HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial August 10, 2015
News Industry News Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial July 07, 2015
News Industry News Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy June 16, 2015